SYNPHASIC 21 TABLETS
SYNPHASIC 21 TABLETS
Approved
DIN Number
02187108
Drug Class
Human
Market Date
Aug 14, 1996
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02187108
AIG Number0414813001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03AB04 NORETHISTERONE AND ESTROGEN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:12.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
ETHINYL ESTRADIOLActive
Strength: 0.035 MG
Monograph: ETHINYL ESTRADIOL
NORETHINDRONEActive
Strength: 1.0 MG
Monograph: NORETHINDRONE
NORETHINDRONEActive
Strength: 0.5 MG
Monograph: NORETHINDRONE